Real-World Effectiveness of Upadacitinib in Moderate‑to‑Seve…

Emerging

0
Citations
0
Refs
2024
Year
Search Works
Work Details
  • DOI 10.25251/skin.8.supp.450
  • OpenAlex ID W4404455182
  • Type Article
  • Language EN
  • Published 18 Nov 2024
  • Volume 8 (6)
  • Pages s450
  • Source SKIN The Journal of Cutaneous Medicine
  • Countries 2
  • Institutions 7
  • Added 18 Nov 2024
  • Updated 24 Oct 2026
External Links
OpenAlex Record DOI Resolver PDF
MENU
0

Real-World Effectiveness of Upadacitinib in Moderate‑to‑Severe Atopic Dermatitis (AD): Results From Longitudinal Analyses of the CorEvitas AD Registry

Article 2024 EN Diamond

Introduction: Clinical trials demonstrated that upadacitinib is efficacious in treating atopic dermatitis (AD). Its real-world effectiveness is less understood. In this study, we investigated the longitudinal real-world outcomes of upadacitinib-treated adults in the CorEvitas AD Registry. Methods: The CorEvitas AD Registry is a prospective, non-interventional registry of adults diagnosed with AD i…

0

Citations

0

References

9

Authors

0.00

FWCI

Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
9 authors
#AuthorInstitutionsORCID
1 Jonathan I. Silverberg George Washington University (US)
2 Melinda Gooderham Queen's University (CA) SKiN Health (CA) +1
3 Christopher G. Bunick Yale University (US)
4 Brian Calimlim AbbVie (United States) (US)
5 Ayman A. Grada AbbVie (United States) (US)
6 Yolanda Muñoz Maldonado —
7 Alvin Li — —
8 Nicole M. Fergestrom —
9 Eric Lawrence Simpson Oregon Health & Science Univer… (US)
Related Works
10

Data: OpenAlex